Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.

Incorporating epidemic history into medical education is crucial to better address post-epidemic health challenges.

Plasma therapy is becoming more popular for treating viral infections, skin conditions, and orthopedic issues, and is expected to grow in the healthcare market.

Platelet-rich plasma treatment shows early improvement in femoral head avascular necrosis.

Platelet-rich plasma treatment shows early improvement in femur head avascular necrosis.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Pharmacists play a key role in managing the use of anxiety medications and ensuring patients use them correctly.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Post-COVID-19 syndrome is complex, affects 5%-10% of people, and requires better research and global collaboration for treatment.

Covid-19 can cause hair loss due to immune and psychological factors.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Testosterone may both worsen and protect against COVID-19 effects in men.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

After moderate COVID-19, cardiovascular patients had fewer respiratory issues but faced new physical and psychological problems.

Non-hospitalized COVID-19 patients often have lingering symptoms for at least 30 days.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.